Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders

被引：78

作者：

Constantinescu, Radu ^{[1
]}

Rosengren, Lars ^{[1
]}

Johnels, Bo ^{[1
]}

Zetterberg, Henrik ^{[2
]}

Holmberg, Bjorn ^{[1
]}

机构：

[1] Sahlgrens Univ Hosp, Dept Neurol, S-41345 Gothenburg, Sweden

[2] Sahlgrens Univ Hosp, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden

来源：

PARKINSONISM & RELATED DISORDERS | 2010年 / 16卷 / 02期

关键词：

Neurofilament triplet protein; Glial fibrillary acidic protein; Cerebrospinal fluid; Parkinsonian disorders; Brain related proteins; MULTIPLE-SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; CSF NEUROFILAMENT; DIAGNOSIS; DIFFERENTIATE; CHAIN;

D O I：

10.1016/j.parkreldis.2009.07.007

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Cerebrospinal fluid (CSF) levels of neurofilament light protein (NFL), a marker of neuronal damage, are normal in Parkinson's disease (PD) but elevated in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Therefore, CSF NFL can help differentiate between PD on one hand and MSA/PSP on the other. In the present study of 10 patients with PD, 21 with MSA, 14 with PSP, 11 with corticobasal degeneration (CBD), and 59 healthy controls, this previous observation is confirmed and also extended to include CBD by showing that similarly high CSF NFL levels are seen not only in MSA and PSP but also in CBD. CSF levels of glial fibrillary acidic protein (GFAP), a protein expressed mainly in fibrillary astrocytes, were similar in all investigated groups. In addition, consecutive analyses of CSF NFL and CSF GFAP levels showed relatively stable levels over time in all the investigated parkinsonian disorders, suggesting that the rate of neuronal degeneration is rather constant over time. Our results suggest that measurements of CSF NFL but not GFAP can be useful in the differential diagnosis of PE) versus atypical parkinsonian disorders (APD). However they do not help differentiate between the different APD. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：142 / 145

页数：4

共 12 条

[1] CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy [J].

Abdo, W. F. ;

de Warrenburg, B. P. C. van ;

Kremer, H. P. H. ;

Bloem, B. R. ;

Verbeek, M. M. .

PARKINSONISM & RELATED DISORDERS, 2007, 13 (08) :480-482

[2] CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease [J].

Abdo, W. Farid ;

Bloem, Bastiaan R. ;

Van Geel, Wieneke J. ;

Esselink, Rianne A. J. ;

Verbeek, Marcel M. .

NEUROBIOLOGY OF AGING, 2007, 28 (05) :742-747

[3] Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease [J].

Abdo, WF ;

de Jong, D ;

Hendriks, JCM ;

Horstink, MWIM ;

Kremer, BPH ;

Bloem, BR ;

Verbeek, MM .

MOVEMENT DISORDERS, 2004, 19 (05) :571-579

[4] Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of parkinsonian syndromes [J].

Brettschneider, Johannes ;

Petzold, Axel ;

Suebssmuth, Sigurd D. ;

Landwehrmeyer, Georg B. ;

Ludolph, Albert C. ;

Kassubek, Jan ;

Tumani, Hayrettin .

MOVEMENT DISORDERS, 2006, 21 (12) :2224-2227

[5] Consensus statement on the diagnosis of multiple system atrophy [J].

Gilman, S ;

Low, P ;

Quinn, N ;

Albanese, A ;

Ben-Shlomo, Y ;

Fowler, C ;

Kaufmann, H ;

Klockgether, T ;

Lang, A ;

Lantos, P ;

Litvan, I ;

Mathias, C ;

Oliver, E ;

Robertson, D ;

Schatz, I ;

Wenning, G .

CLINICAL AUTONOMIC RESEARCH, 1998, 8 (06) :359-362

[6] Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease [J].

Holmberg, B ;

Rosengren, L ;

Karlsson, JE ;

Johnels, B .

MOVEMENT DISORDERS, 1998, 13 (01) :70-77

[7]

Lang A., 1994, Neurodegenerative Diseases, P877

[8] Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop [J].

Litvan, I ;

Agid, Y ;

Calne, D ;

Campbell, G ;

Dubois, B ;

Duvoisin, RC ;

Goetz, CG ;

Golbe, LI ;

Grafman, J ;

Growdon, JH ;

Hallett, M ;

Jankovic, J ;

Quinn, NP ;

Tolosa, E ;

Zee, DS ;

Chase, TN ;

FitzGibbon, EJ ;

Hall, Z ;

Juncos, J ;

Nelson, KB ;

Oliver, E ;

Pramstaller, P ;

Reich, SG ;

Verny, M .

NEUROLOGY, 1996, 47 (01) :1-9

[9] Elevated neurofilament levels in neurological [J].

Norgren, N ;

Rosengren, L ;

Stigbrand, T .

BRAIN RESEARCH, 2003, 987 (01) :25-31

[10] A SENSITIVE ELISA FOR GLIAL FIBRILLARY ACIDIC PROTEIN - APPLICATION IN CSF OF ADULTS [J].

ROSENGREN, LE ;

WIKKELSO, C ;

HAGBERG, L .

JOURNAL OF NEUROSCIENCE METHODS, 1994, 51 (02) :197-204

← 1 2 →